---
figid: PMC2701885__JCI39133.f2
figlink: /pmc/articles/PMC2701885/figure/F2/
number: F2
caption: (A) Hepatocytes sense HCV dsRNA structures via pattern recognition receptors
  RIG-I and TLR3. These receptors activate via their adaptor molecules IPS-1 and TRIF,
  respectively, NF-κB, and the downstream kinases IKKε and TNF receptor–associated
  factor family member–associated NF-κB activator–binding kinase–1 (TBK1). IKKε and
  TBK1 phosphorylate the transcription factor IRF3, which dimerizes, translocates
  to the nucleus, and activates IFN-β gene transcription in synergy with NF-κB. HCV
  NS3/4A cleaves the adapter molecules TRIF and IPS-1, thereby blocking TLR3 and RIG-I
  signaling. (B) Binding of IFN-β to the IFN-α/β receptor (IFNAR-1 and -2) activates
  the JAK/STAT pathway. Specifically, TYK2 and JAK1 kinase activation results in the
  generation, phosphorylation, and assembly of the trimeric ISGF3 transcription factor
  complex, which consists of a STAT1–STAT2 heterodimer and IRF9. This complex translocates
  to the nucleus, binds to IFN-stimulated response elements (ISREs) within the promoter/enhancer
  region of ISGs and induces 2′-5′ OAS, PKR, and IRF7 production. HCV core interferes
  with the JAK/STAT pathway by inducing SOCS1/3 and by inhibiting STAT1 phosphorylation.
  The HCV polyprotein induces protein phosphatase 2A (PP2A), which interferes with
  STAT1 methylation, thereby increasing the binding of STAT1 to protein inhibitor
  of activated STAT1 (PIAS). STAT1/PIAS interaction impairs the binding of the ISGF3
  complex to the IFN-stimulated response element and blocks the transcription of ISGs.
  HCV E2 and HCV NS5A inhibit the function of several ISGs (see text for details).
pmcid: PMC2701885
papertitle: 'Hepatitis C virus versus innate and adaptive immune responses: a tale
  of coevolution and coexistence.'
reftext: Barbara Rehermann. J Clin Invest. 2009 Jul 1;119(7):1745-1754.
pmc_ranked_result_index: '82621'
pathway_score: 0.9543173
filename: JCI39133.f2.jpg
figtitle: 'Hepatitis C virus versus innate and adaptive immune responses: a tale of
  coevolution and coexistence'
year: '2009'
organisms:
- Homo sapiens
ndex: 55e9f17e-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2701885__JCI39133.f2.html
  '@type': Dataset
  description: (A) Hepatocytes sense HCV dsRNA structures via pattern recognition
    receptors RIG-I and TLR3. These receptors activate via their adaptor molecules
    IPS-1 and TRIF, respectively, NF-κB, and the downstream kinases IKKε and TNF receptor–associated
    factor family member–associated NF-κB activator–binding kinase–1 (TBK1). IKKε
    and TBK1 phosphorylate the transcription factor IRF3, which dimerizes, translocates
    to the nucleus, and activates IFN-β gene transcription in synergy with NF-κB.
    HCV NS3/4A cleaves the adapter molecules TRIF and IPS-1, thereby blocking TLR3
    and RIG-I signaling. (B) Binding of IFN-β to the IFN-α/β receptor (IFNAR-1 and
    -2) activates the JAK/STAT pathway. Specifically, TYK2 and JAK1 kinase activation
    results in the generation, phosphorylation, and assembly of the trimeric ISGF3
    transcription factor complex, which consists of a STAT1–STAT2 heterodimer and
    IRF9. This complex translocates to the nucleus, binds to IFN-stimulated response
    elements (ISREs) within the promoter/enhancer region of ISGs and induces 2′-5′
    OAS, PKR, and IRF7 production. HCV core interferes with the JAK/STAT pathway by
    inducing SOCS1/3 and by inhibiting STAT1 phosphorylation. The HCV polyprotein
    induces protein phosphatase 2A (PP2A), which interferes with STAT1 methylation,
    thereby increasing the binding of STAT1 to protein inhibitor of activated STAT1
    (PIAS). STAT1/PIAS interaction impairs the binding of the ISGF3 complex to the
    IFN-stimulated response element and blocks the transcription of ISGs. HCV E2 and
    HCV NS5A inhibit the function of several ISGs (see text for details).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA2
  - IFNA1
  - IFNA13
  - TLR3
  - IFNAR1
  - NFKB1
  - DDX58
  - IRF3
  - IRF7
  - EIF2AK2
  - IFNA10
  - STAT1
  - IFNA17
  - IFNA14
  - JAK1
  - ISYNA1
  - STAT2
  - TBK1
  - TYK2
  - IFNA16
  - SOCS3
  - IFNA6
  - IFNA5
  - IFNAR2
  - SOCS1
  - IFNA4
  - IKBKE
  - IFNA8
  - IFNA7
  - IRF9
  - CHUK
  - IFNA21
  - IFNB1
  - CXCL8
genes:
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IFNAR-1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: IFN-a
  symbol: IFN-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7,
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: 2'-5'OAS,PKR,IRF7,
  symbol: PKR
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK2
  entrez: '5610'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: IPS
  symbol: IPS
  source: hgnc_alias_symbol
  hgnc_symbol: ISYNA1
  entrez: '51477'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: TBK1/IKKE
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: SOCS1/3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: ISGF3
  symbol: ISGF-3
  source: hgnc_alias_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNAR-2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: SOCS1/3
  symbol: SOCS1
  source: hgnc_symbol
  hgnc_symbol: SOCS1
  entrez: '8651'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: TBK1/IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: IKKa/ß
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IFN-a--
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFN-B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
chemicals: []
diseases: []
figid_alias: PMC2701885__F2
redirect_from: /figures/PMC2701885__F2
figtype: Figure
---
